| Literature DB >> 35336998 |
Xiuhong Wu1,2,3, Yuanjia Liu4, Liguo Gao1,2,3, Zhuanqiang Yan5, Qiqi Zhao1,2,3, Feng Chen1,2,3, Qingmei Xie1,2,3, Xinheng Zhang1,2,3.
Abstract
Porcine epidemic diarrhea virus (PEDV) is a coronavirus currently widespread worldwide in the swine industry. Since PEDV was discovered in China in 1984, it has caused huge economic losses in the swine industry. PEDV can infect pigs of all ages, but piglets have the highest infection with a death rate as high as 100%, and the clinical symptoms are watery diarrhea, vomiting, and dehydration. At present, there is not any report on PEDV detection by RT-RAA. In this study, we developed an isothermal amplification technology by using reverse-transcription recombinase-aided amplification assay (RT-RAA) combined with portable instruments to achieve a molecular diagnosis of PEDV in clinical samples from China. By designing a pair of RT-RAA primers and probes based on the PEDV N gene, this method breaks the limitations of existing detection methods. The assay time was within 30 min at 41 °C and can detect as few as 10 copies of PEDV DNA molecules per reaction. Sixty-two clinical tissue samples were detected by RT-qPCR and RT-RAA. The positive and negative rates for the two methods were 24.19% and 75.81%, respectively. Specificity assay showed that the RT-RAA had specifically detected PEDV and was not reactive for porcine parvovirus (PPV), transmissible gastroenteritis virus (TGEV), porcine circovirus type 2 (PCV2), porcine pseudorabies virus (PRV), porcine reproductive and respiratory syndrome virus (PRRSV), classical swine fever virus (CSFV), swine flu virus (SIV), or porcine Japanese encephalitis virus (JEV). The results suggested that RT-RAA had a strong specificity and high detection sensitivity when combined with a portable instrument to complete the detection under a constant temperature of 30 min, which are more suitable for preventing and controlling PEDV onsite in China.Entities:
Keywords: clinical diagnosis; constant temperature detection; porcine epidemic diarrhea virus; reverse-transcription recombinase-aided amplification assay
Mesh:
Substances:
Year: 2022 PMID: 35336998 PMCID: PMC8948910 DOI: 10.3390/v14030591
Source DB: PubMed Journal: Viruses ISSN: 1999-4915 Impact factor: 5.048
Figure 1Schematic representation of the RAA-based amplification process: (A) reaction mechanism based on RAA recombination; (B) principle of real-time fluorescent RT-RAA.
Sequences of primers and probes for real-time RT-RAA assay.
| Primer/Probe | Sequence (5′–3′) | Gen Localization |
|---|---|---|
| F-Primer | AATCGTGGAAATAACCAGGGTCGTGGAG | 26904–26931 |
| R-Primer | CAAAGATTTAAGGGCATCCTTGACAGCAG | 27046–27074 |
| P-Probe | AACAGAGGAGGCAATAATAATAACAATAACAAG | 26940–26990 |
The real-time RT-RAA reaction system preparation table.
| RT-RAA Reaction System | Usage |
|---|---|
| RT-RAA freeze-dried powder | 1 tube |
| A buffer | 25 µL |
| B buffer | 2.5 µL |
| F-Primer (10µM) | 2 µL |
| R-Primer (10µM) | 2 µL |
| P-Probe (10µM) | 0.6 µL |
| H2O | 15.9 µL |
| RNA | 2 µL |
| Total | 50 µL |
Figure 2The agarose gel electrophoresis results of PCR amplified products with the real-time RT-RAA primers. M: D 2000 marker; P: positive control, i.e., PEDV N gene plasmid; N: negative control, i.e., ddH2O.
Figure 3Sensitivity analysis of the real-time RT-RAA assay. The dilution range of the PEDV-N gene plasmid was 101 to 105 copies/µL, and the lowest detection line was 101 copies/µL.
Figure 4Specificity analysis of the real-time RT-RAA assay. The RT-RAA method specifically detected PEDV nucleic acid, and had no cross-reactivity with porcine parvovirus (PPV), transmissible gastroenteritis virus (TGEV), porcine circovirus type 2 (PCV2), porcine pseudorabies virus (PRV), porcine reproductive and respiratory syndrome virus (PRRSV), classical swine fever virus (CSFV), swine flu virus (SIV), or porcine Japanese encephalitis virus (JEV) nucleic acid. The figure is a representative result of the three independent experiments.
Figure 5Repeatability analysis of the real-time RT-RAA assay. The real-time RT-RAA assay was repeated three times with 103 copies/µL, 102 copies/µL, and 101 copies/µL.
Data from the repeatability analysis of the real-time RT-RAA assay.
| Templates (Copies/µL) | 1 | 2 | 3 | Average ± SD | CV% |
|---|---|---|---|---|---|
| 101 | 15.01 | 15.34 | 15.71 | 15.35 ± 0.35 | 2.28 |
| 102 | 7.69 | 8.05 | 7.25 | 7.66 ± 0.40 | 5.23 |
| 103 | 4.99 | 4.47 | 4.66 | 4.71 ± 0.26 | 5.59 |
The results of clinical tests.
| Methods and Determination Indexes | Positive Tissue Numbers | Negative Tissue Numbers | Total |
|---|---|---|---|
| Commercial RT-qPCR | 15 | 47 | 62 |
| RT-RAA | 15 | 47 | 62 |
| Positive rate (%) | 24.19 | - | - |
| Negative rate (%) | - | 75.81 | - |
| Coincidence rate (%) | 100 | 100 | - |